DCF — FOUNDATION SURGICAL OF SAN ANTONIO
Enterprise Value: $0.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$0.4M
Enterprise Value
$-0.9M
PV of Cash Flows
$1.3M
PV of Terminal Value
$2.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $39.3M | $1.0M | 3.0% | $-0.7M | $-0.6M |
| Year 2 | $40.4M | $1.4M | 4.0% | $-0.4M | $-0.3M |
| Year 3 | $41.7M | $1.9M | 5.0% | $-0.1M | $-0.1M |
| Year 4 | $42.9M | $2.2M | 5.0% | $0.1M | $0.0M |
| Year 5 | $44.2M | $2.3M | 5.0% | $0.2M | $0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $0.4M. Terminal value accounts for 297% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$38.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02022666106815376
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5